{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:24:40Z","timestamp":1791915880551,"version":"4.3.4"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl Int"],"abstract":"<jats:p>Liver xenotransplantation has emerged as a potential solution to the shortage of deceased human donor organs and is now becoming a reality due to recent developments in genetic engineering and immunosuppressive therapy. Early efforts using non-human primates and genetically modified pigs faced significant challenges such as thrombocytopenia and graft rejection. Understanding the mechanism behind those challenges and using novel genetically engineered pigs enabled researchers to overcome some of the hurdles, but more research is needed. However, new advances might allow pig liver xenotransplantation to potentially serve as a bridge to liver allotransplantation or allow native liver regeneration in the near future.<\/jats:p>","DOI":"10.3389\/ti.2024.14040","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T04:11:19Z","timestamp":1735877479000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Liver Xenotransplantation: A Path to Clinical Reality"],"prefix":"10.3389","volume":"37","author":[{"given":"Serkan","family":"Sucu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucel","family":"Yankol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcin","family":"Ekser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of Chronic Liver Diseases in the USA in the Past Three Decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/cld.1061","article-title":"Global Epidemiology of Chronic Liver Disease","volume":"17","author":"Cheemerla","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/ajt.16494","article-title":"OPTN\/SRTR 2019 Annual Data Report: Liver","volume":"21","author":"Kwong","year":"2021","journal-title":"Am J Transpl"},{"key":"B4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.7326\/M15-2211","article-title":"Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study","volume":"164","author":"Reuben","year":"2016","journal-title":"Ann Intern Med"},{"key":"B5","unstructured":"National Data on Organ Procurement and Transplantation Network (OPTN)2024"},{"key":"B6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/MOT.0000000000000623","article-title":"Liver Transplantation for Colorectal Liver Metastasis","volume":"24","author":"Simoneau","year":"2019","journal-title":"Curr Opin Organ Transpl"},{"key":"B7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/lt.21476","article-title":"Liver Xenografts for the Treatment of Acute Liver Failure: Clinical and Experimental Experience and Remaining Immunologic Barriers","volume":"14","author":"Hara","year":"2008","journal-title":"Liver Transpl"},{"key":"B8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12033-017-0024-9","article-title":"Genetically Modified Pigs as Organ Donors for Xenotransplantation","volume":"59","author":"Hryhorowicz","year":"2017","journal-title":"Mol Biotechnol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2201422","article-title":"Genetically Modified Porcine-To-Human Cardiac Xenotransplantation","volume":"387","author":"Griffith","year":"2022","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/d41586-024-00879-y","article-title":"First Pig Kidney Transplant in a Person: What It Means for the Future","volume":"628","author":"Mallapaty","year":"2024","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"827535","DOI":"10.3389\/fimmu.2022.827535","article-title":"Current Barriers to Clinical Liver Xenotransplantation","volume":"13","author":"Cross-Najafi","year":"2022","journal-title":"Front Immunol"},{"key":"B12","volume-title":"Experience in Hepatic Transplantation","author":"Starzl","year":"1969"},{"key":"B13","first-page":"506","article-title":"Clinical Heterotransplantation of the Liver","volume":"2","author":"Giles","year":"1970","journal-title":"Transpl Proc"},{"key":"B14","first-page":"347","article-title":"Attempt at Treatment of Various Severe Acute Hepatic Insufficiencies by Temporary Heterotopic Heterologous Liver Graft (Baboon Liver)","volume":"222","author":"Bertoye","year":"1969","journal-title":"Lyon Med"},{"key":"B15","first-page":"13","article-title":"Clinical Xenotransplantation: Past, Present and Future","volume":"79","author":"Taniguchi","year":"1997","journal-title":"Ann R Coll Surg Engl"},{"key":"B16","first-page":"161","article-title":"Treatment of Hepatic Coma by Purification in a Heterologous Liver","volume":"97","author":"Leger","year":"1969","journal-title":"J Chir (Paris)"},{"key":"B17","first-page":"288","article-title":"Two Cases of True Heterotopic Transplantation of Baboon Livers in Malignant Acute Hepatitis","volume":"67","author":"Pouyet","year":"1971","journal-title":"Lyon Chir"},{"key":"B18","first-page":"4","article-title":"Human Liver Xenotransplantation","volume":"1","author":"Starzl","year":"1993","journal-title":"Xeno"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1097\/00007890-199506270-00002","article-title":"The Use of a Pig Liver Xenograft for Temporary Support of a Patient With Fulminant Hepatic Failure","volume":"59","author":"Makowka","year":"1995","journal-title":"Transplantation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/d41586-024-01613-4","article-title":"First Pig-To-Human Liver Transplant Recipient \u201cDoing Very Well\u201d","volume":"630","author":"Mallapaty","year":"2024","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12306","article-title":"Early Clinical Xenotransplantation Experiences - An Interview with Thomas E. Starzl, MD, PhD","volume":"24","author":"Cooper","year":"2017","journal-title":"Xenotransplantation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0140-6736(93)92553-6","article-title":"Baboon-to-Human Liver Transplantation","volume":"341","author":"Starzl","year":"1993","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/path.4635","article-title":"The Role of Genetically-Engineered Pigs in Xenotransplantation Research","volume":"238","author":"Cooper","year":"2016","journal-title":"J Pathol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/tan.12669","article-title":"The Immunological Barriers to Xenotransplantation","volume":"86","author":"Vadori","year":"2015","journal-title":"Tissue Antigens"},{"key":"B25","first-page":"99","article-title":"Cellular Immune Responses to Xenografts","volume-title":"Xenotransplantation","author":"Gill","year":"2000"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1016\/j.transproceed.2005.09.186","article-title":"Prevention of Hyperacute Rejection in a Model of Orthotopic Liver Xenotransplantation From Pig to Baboon Using Polytransgenic Pig Livers (CD55, CD59, and H-Transferase)","volume":"37","author":"Ramirez","year":"2005","journal-title":"Transpl Proc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/00007890-200010150-00001","article-title":"Life-Supporting Human Complement Regulator Decay Accelerating Factor Transgenic Pig Liver Xenograft Maintains the Metabolic Function and Coagulation in the Nonhuman Primate for Up to 8 Days","volume":"70","author":"Ramirez","year":"2000","journal-title":"Transplantation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1073\/pnas.84.5.1369","article-title":"Evolutionary Relationship Between the Natural Anti-Gal Antibody and the Gal Alpha 1----3Gal Epitope in Primates","volume":"84","author":"Galili","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","first-page":"559","article-title":"Identification of Carbohydrate Structures That Bind Human Antiporcine Antibodies: Implications for Discordant Xenografting in Humans","volume":"24","author":"Good","year":"1992","journal-title":"Transpl Proc"},{"key":"B30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/978-1-4615-4771-6_10","article-title":"Anti-Gal, Alpha-Gal Epitopes, and Xenotransplantation","volume":"32","author":"Kobayashi","year":"1999","journal-title":"Subcell Biochem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/0140-6736(93)91791-j","article-title":"Genetically Engineered Pigs","volume":"342","author":"Cooper","year":"1993","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nbt0302-251","article-title":"Targeted Disruption of the Alpha1,3-Galactosyltransferase Gene in Cloned Pigs","volume":"20","author":"Dai","year":"2002","journal-title":"Nat Biotechnol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1126\/science.1078942","article-title":"Production of Alpha 1,3-Galactosyltransferase-Deficient Pigs","volume":"299","author":"Phelps","year":"2003","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"7335","DOI":"10.1073\/pnas.0307819101","article-title":"Production of Alpha-1,3-Galactosyltransferase Null Pigs by Means of Nuclear Transfer With Fibroblasts Bearing Loss of Heterozygosity Mutations","volume":"101","author":"Kolber-Simonds","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm1171","article-title":"Heart Transplantation in Baboons Using Alpha1,3-Galactosyltransferase Gene-Knockout Pigs as Donors: Initial Experience","volume":"11","author":"Kuwaki","year":"2005","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nm1172","article-title":"Marked Prolongation of Porcine Renal Xenograft Survival in Baboons through the Use of \u03b11,3-galactosyltransferase Gene-Knockout Donors and the Cotransplantation of Vascularized Thymic Tissue","volume":"11","author":"Yamada","year":"2005","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/TP.0b013e3181e98d51","article-title":"Hepatic Function After Genetically Engineered Pig Liver Transplantation in Baboons","volume":"90","author":"Ekser","year":"2010","journal-title":"Transplantation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1399-3089.2004.00187.x","article-title":"O-linked glycosylation and Functional Incompatibility of Porcine von Willebrand Factor for Human Platelet GPIb Receptors","volume":"12","author":"Schulte","year":"2005","journal-title":"Xenotransplantation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1399-3089.2011.00639.x","article-title":"ASGR1 Expressed by Porcine Enriched Liver Sinusoidal Endothelial Cells Mediates Human Platelet Phagocytosis In Vitro","volume":"18","author":"Paris","year":"2011","journal-title":"Xenotransplantation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nri1859","article-title":"The SIRP Family of Receptors and Immune Regulation","volume":"6","author":"Barclay","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000374067","article-title":"Pig BMSCs Transfected With Human TFPI Combat Species Incompatibility and Regulate the Human TF Pathway In Vitro and in a Rodent Model","volume":"36","author":"Ji","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1399-3089.2010.00605.x","article-title":"The Fate of Human Platelets Perfused Through the Pig Liver: Implications for Xenotransplantation","volume":"17","author":"Burlak","year":"2010","journal-title":"Xenotransplantation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1600-6143.2009.02945.x","article-title":"Impact of Thrombocytopenia on Survival of Baboons With Genetically Modified Pig Liver Transplants: Clinical Relevance","volume":"10","author":"Ekser","year":"2010","journal-title":"Am J Transpl"},{"key":"B44","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1399-3089.2012.00717.x","article-title":"Up to 9-Day Survival and Control of Thrombocytopenia Following Alpha1,3-Galactosyl Transferase Knockout Swine Liver Xenotransplantation in Baboons","volume":"19","author":"Kim","year":"2012","journal-title":"Xenotransplantation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e12834","DOI":"10.1111\/xen.12834","article-title":"Xenoreactive Antibodies in \u03b1-Granules of Human Platelets Bind Pig Liver Endothelial Cells","volume":"30","author":"Burlak","year":"2023","journal-title":"Xenotransplantation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/MOT.0b013e3283446c65","article-title":"Controlling Coagulation Dysregulation in Xenotransplantation","volume":"16","author":"Cowan","year":"2011","journal-title":"Curr Opin Organ Transpl"},{"key":"B47","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/TP.0b013e31818410a3","article-title":"Expression of Tissue Factor and Initiation of Clotting by Human Platelets and Monocytes After Incubation With Porcine Endothelial Cells","volume":"86","author":"Lin","year":"2008","journal-title":"Transplantation"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1111\/ajt.13647","article-title":"The Effects of Exogenous Administration of Human Coagulation Factors Following Pig-To-Baboon Liver Xenotransplantation","volume":"16","author":"Navarro-Alvarez","year":"2016","journal-title":"Am J Transpl"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/SLA.0000000000001659","article-title":"A Bridge to Somewhere: 25-Day Survival After Pig-To-Baboon Liver Xenotransplantation","volume":"263","author":"Shah","year":"2016","journal-title":"Ann Surg"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1111\/ajt.14341","article-title":"Prolonged Survival Following Pig-To-Primate Liver Xenotransplantation Utilizing Exogenous Coagulation Factors and Costimulation Blockade","volume":"17","author":"Shah","year":"2017","journal-title":"Am J Transpl"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3390\/ani10091695","article-title":"Ethical and Societal Issues Occasioned by Xenotransplantation","volume":"10","author":"Rollin","year":"2020","journal-title":"Animals (Basel)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0024","DOI":"10.5041\/RMMJ.10511","article-title":"The Jewish Perspectives on Xenotransplantation","volume":"14","author":"Loike","year":"2023","journal-title":"Rambam Maimonides Med J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e12400","DOI":"10.1111\/xen.12400","article-title":"Jewish, Christian and Muslim Theological Perspectives about Xenotransplantation","volume":"25","author":"Paris","year":"2018","journal-title":"Xenotransplantation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/MOT.0000000000000463","article-title":"Xenotransplantation: Past, Present, and Future","volume":"22","author":"Ekser","year":"2017","journal-title":"Curr Opin Organ Transpl"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.14040\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T04:11:26Z","timestamp":1735877486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.14040\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":54,"alternative-id":["10.3389\/ti.2024.14040"],"URL":"https:\/\/doi.org\/10.3389\/ti.2024.14040","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"article-number":"14040"}}